Ann: Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO, page-27

any genuine holder harping on about the AGM and considering voting for a 2nd strike has rocks in their head, in addition to not liking money (their own, if invested here).

such a short sighted view that will only damage their own investment immediately, as well as delay the process of seeing this awe inspiring tech reach the patients who need it.

Imugene management and the board are doing an exceptional job, doing their job. they cannot however, prop up the share price in a risk off macro environment, or give these few (but loud and repetitive) disgruntled posters a hug about their underwater investment.

the quality of management and their past achievements and performance should be one of the first investment criteria, and this team are 2nd to none. for anyone who disagrees, i question why you’re invested here in the first place.

grow up and own your investment decisions, or choose a space more aligned with your risk profiles. you want your bio cake and the potential rewards the space represents, then you eat the risk it entails too